跳至主要内容
临床试验/CTRI/2025/02/080502
CTRI/2025/02/080502
尚未招募
2 期

An open label randomized controlled clinical trial to evaluate the efficacy of multimodality Ayurveda interventions in the management of Autism Spectrum Disorder.

Parul Institute of Ayurved1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年2月18日最近更新:

概览

阶段
2 期
状态
尚未招募
发起方
Parul Institute of Ayurved
入组人数
30
试验地点
1
主要终点
Improvement in Cognition on ISAA Scale

概览

简要总结

Autism is Neurobehavioral disorder with wide range of clinical features and presentations. behavioral therapy is the established medical management for the same. Ayurveda therapies which helps to improve the cognition and concentration along with gold salts is is helpful to treat the clinical outcome of the disease. present trial highlights abd aim to establish the Ayurveda therapy alomg with conventional behaviour therapy

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
5.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Patient with known cases of ASD children belonging to the age group of 5 to 12 years, irrespective of gender, caste, religion and socio- economic status.

排除标准

  • Patients with known case of acute and chronic systemic illness such as renal disease, hepatic dysfunction, malignancy, tuberculosis.
  • ASD associated with other neurobehavior or neurodevelopmental disorders.

结局指标

主要结局

Improvement in Cognition on ISAA Scale

时间窗: Day 30 day 60 and Day 90

Improvement in Social behaviour and speech

时间窗: Day 30 day 60 and Day 90

次要结局

  • Improvement in Quality of life(Day 30 day 60 and Day 90)

研究者

发起方
Parul Institute of Ayurved
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Riya Patel

Parul Institute of Ayurved

研究点 (1)

Loading locations...

相似试验